38 results on '"Papa, Silvia"'
Search Results
2. Right ventricular phenotyping in incident patients with idiopathic pulmonary arterial hypertension
3. Comparative effectiveness of oral therapies targeting the prostacyclin pathway in pulmonary arterial hypertension: A systematic review and network meta-analysis
4. Defining the clinical validity of genes reported to cause pulmonary arterial hypertension
5. The importance of re-evaluating the risk score in heart failure patients: An analysis from the Metabolic Exercise Cardiac Kidney Indexes (MECKI) score database
6. Pulmonary pressure recovery in idiopathic, hereditary and drug and toxin-induced pulmonary arterial hypertension: determinants and clinical impact
7. Incremental value of cardiopulmonary exercise testing in intermediate-risk pulmonary arterial hypertension
8. Right Ventricular Strain Curve Morphology and Outcome in Idiopathic Pulmonary Arterial Hypertension
9. Hemodynamics and risk assessment 2 years after the initiation of upfront ambrisentan‒tadalafil in pulmonary arterial hypertension
10. Intra-aortic balloon counterpulsation timing: A new numerical model for programming and training in the clinical environment.
11. Clinical implications of idiopathic pulmonary arterial hypertension phenotypes defined by cluster analysis
12. The importance of right ventricular evaluation in risk assessment and therapeutic strategies: Raising the bar in pulmonary arterial hypertension
13. Risk Reduction and Right Heart Reverse Remodeling by Upfront Triple Combination Therapy in Pulmonary Arterial Hypertension
14. Exercise energy expenditure in patients with idiopathic pulmonary arterial hypertension: Impact on clinical severity and survival
15. The added value of cardiopulmonary exercise testing in the follow-up of pulmonary arterial hypertension
16. Prognostic significance of the echocardiographic estimate of pulmonary hypertension and of right ventricular dysfunction in acute decompensated heart failure. A pilot study in HFrEF patients
17. Prognostic relevance of right heart reverse remodeling in idiopathic pulmonary arterial hypertension
18. Fixed-dose combination therapy in pulmonary arterial hypertension: Pros & cons
19. Echocardiography Combined With Cardiopulmonary Exercise Testing for the Prediction of Outcome in Idiopathic Pulmonary Arterial Hypertension
20. Right ventricular concentric hypertrophy and clinical worsening in idiopathic pulmonary arterial hypertension
21. Right Intraventricular Dyssynchrony in Idiopathic, Heritable, and Anorexigen-Induced Pulmonary Arterial Hypertension: Clinical Impact and Reversibility
22. Right ventricular remodeling in idiopathic pulmonary arterial hypertension: adaptive versus maladaptive morphology
23. Right ventricular dyssynchrony in idiopathic pulmonary arterial hypertension: Determinants and impact on pump function
24. Right heart reverse remodeling: “facta non verba”
25. WITHDRAWN: Comparative effectiveness of oral therapies targeting the prostacyclin pathway in pulmonary arterial hypertension: A systematic review and network meta-analysis
26. Relationship between baseline ET-1 plasma levels and outcome in patients with idiopathic pulmonary hypertension treated with bosentan
27. Therapy for pulmonary arterial hypertension due to congenital heart disease and Down's syndrome
28. Telehealth: A winning weapon to face the COVID-19 outbreak for patients with pulmonary arterial hypertension
29. Prognostic factors in severe pulmonary hypertension patients who need parenteral prostanoid therapy: The impact of late referral
30. Usefulness of Adding Echocardiography of the Right Heart to Risk-Assessment Scores in Prostanoid-Treated Pulmonary Arterial Hypertension
31. The Authors Reply
32. Right ventricular assessment matters for precision medicine. Reply to “Identifying parameters associated with response to switching from a PDE5i to riociguat in RESPITE”
33. Incidence and long-term outcomes of pregnant women complicated with pulmonary arterial hypertension during different pregnancies: A prospective cohort study from China
34. Multidimensional assessment and cluster analysis for idiopathic pulmonary arterial hypertension phenotyping
35. Letter to the editor about the paper “Right ventricular dyssynchrony predicts clinical outcomes in patients with pulmonary hypertension” by Murata et al.
36. Pulmonary Arterial Hypertension Related to Congenital Heart Disease: Does the Presence of Down's Syndrome Affect the Safety and the Efficacy of Bosentan Therapy?
37. Prognostic Factors in Severe Pulmonary Hypertension Patients Who Need Parenteral Prostanoid Therapy: The Impact of Late Referral
38. Impact of RV Remodelling on Survival in PAH Patients: Role of RV Mass/Volume Ratio
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.